ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Akne-mycin®/- 2000:Almirall AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
D10AF02 - ErythromycinATC-DDD Version 2016. Source: WHO
D - Dermatologicals

Most of the drugs in this group are preparations for topical use. Some few preparations for systemic use with clear dermatological applications, e.g. griseofulvin (antimycotic), retinoids (for treatment of acne) and psoralens and retinoids (for treatment of psoriasis) are classified in this group.

Only oral preparations in ATC group D are given DDDs. Most products in this group are for topical use, and no DDDs are assigned because the amount given per day can vary very much according to the intensity and distribution of the disease. Consumption figures for these dermatological preparations can be expressed in grams of preparations regardless of strength.

D10 - Anti-Acne Preparations
 

The DDDs are based on the treatment of severe acne.

D10A - Anti-Acne Preparations for Topical Use

This group comprises all topical preparations used specifically in the treatment of acne, incl. preparations with antibiotics, corticosteroids etc.

D10AF - Antiinfectives for Treatment Of Acne

This group comprises antibiotics for topical use with acne as the main indication.
Other topical antiinfectives are classified in D06 - Antibiotics and chemotherapeutics for dermatological use.
Combinations with retinoids are classified in D10AD.

D10AF02 - Erythromycin
2020 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home